Inge van Rooy

643 total citations
10 papers, 520 citations indexed

About

Inge van Rooy is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Inge van Rooy has authored 10 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Biomaterials and 3 papers in Biomedical Engineering. Recurrent topics in Inge van Rooy's work include Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Inge van Rooy is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), RNA Interference and Gene Delivery (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Inge van Rooy collaborates with scholars based in Netherlands, United States and Norway. Inge van Rooy's co-authors include Raymond M. Schiffelers, Gert Storm, Enrico Mastrobattista, Wim E. Hennink, Willem J. M. Mulder, Zahi A. Fayad, Aneta J. Mieszawska, Róbert Langer, Artiom Petrov and Bram Priem and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Inge van Rooy

10 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inge van Rooy Netherlands	9	260	245	156	70	49	10	520
Julia V. Georgieva United States	10	252 1.0×	300 1.2×	121 0.8×	78 1.1×	42 0.9×	13	608
Shuaiqi Pan China	7	470 1.8×	435 1.8×	263 1.7×	65 0.9×	37 0.8×	8	748
Zhuxuan Jiang China	9	396 1.5×	347 1.4×	247 1.6×	59 0.8×	37 0.8×	11	672
Zui Zhang China	8	370 1.4×	308 1.3×	219 1.4×	49 0.7×	23 0.5×	11	573
Christina L. Parker United States	8	178 0.7×	218 0.9×	108 0.7×	43 0.6×	48 1.0×	11	428
Kasper Kristensen Denmark	11	192 0.7×	290 1.2×	132 0.8×	34 0.5×	22 0.4×	18	484
Tran Nguyen Finland	5	220 0.8×	345 1.4×	92 0.6×	48 0.7×	45 0.9×	8	592
Alice Gaudin United States	11	264 1.0×	243 1.0×	188 1.2×	83 1.2×	13 0.3×	16	582
Zhangjie Xi China	6	409 1.6×	388 1.6×	338 2.2×	57 0.8×	31 0.6×	8	753

Countries citing papers authored by Inge van Rooy

Since Specialization

Citations

This map shows the geographic impact of Inge van Rooy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge van Rooy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge van Rooy more than expected).

Fields of papers citing papers by Inge van Rooy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge van Rooy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge van Rooy. The network helps show where Inge van Rooy may publish in the future.

Co-authorship network of co-authors of Inge van Rooy

This figure shows the co-authorship network connecting the top 25 collaborators of Inge van Rooy. A scholar is included among the top collaborators of Inge van Rooy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge van Rooy. Inge van Rooy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Drabbels, J.J.M., Inge van Rooy, Guro M. Johnsen, et al.. (2020). HLA‐G whole gene amplification reveals linkage disequilibrium between the HLA‐G 3′UTR and coding sequence. HLA. 96(2). 179–185. 12 indexed citations

Mieszawska, Aneta J., YongTae Kim, Anita Gianella, et al.. (2013). Synthesis of Polymer–Lipid Nanoparticles for Image-Guided Delivery of Dual Modality Therapy. Bioconjugate Chemistry. 24(9). 1429–1434. 86 indexed citations

Zhao, Yiming, Inge van Rooy, Sjoerd Hak, et al.. (2013). Near-Infrared Fluorescence Energy Transfer Imaging of Nanoparticle Accumulation and Dissociation Kinetics in Tumor-Bearing Mice. ACS Nano. 7(11). 10362–10370. 59 indexed citations

Rooy, Inge van, et al.. (2011). Preparation and characterization of liposomal formulations of neurotensin-degrading enzyme inhibitors. International Journal of Pharmaceutics. 416(2). 448–452. 2 indexed citations

Rooy, Inge van, Wim E. Hennink, Gert Storm, Raymond M. Schiffelers, & Enrico Mastrobattista. (2011). Attaching the phage display-selected GLA peptide to liposomes: Factors influencing target binding. European Journal of Pharmaceutical Sciences. 45(3). 330–335. 22 indexed citations

Rooy, Inge van, et al.. (2010). In Vivo Methods to Study Uptake of Nanoparticles into the Brain. Pharmaceutical Research. 28(3). 456–471. 103 indexed citations

Rooy, Inge van, Enrico Mastrobattista, Gert Storm, Wim E. Hennink, & Raymond M. Schiffelers. (2010). Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. Journal of Controlled Release. 150(1). 30–36. 155 indexed citations

Rooy, Inge van, Pierre‐Olivier Couraud, Ignacio A. Romero, et al.. (2010). Identification of Peptide Ligands for Targeting to the Blood-Brain Barrier. Pharmaceutical Research. 27(4). 673–682. 58 indexed citations

Schiffelers, Raymond M., et al.. (2007). Synthetic Delivery Systems for Intravenous Administration of Nucleic Acids. Nanomedicine. 2(2). 169–181. 12 indexed citations

10.

Schiffelers, Raymond M., Inge van Rooy, & Gert Storm. (2005). siRNA-mediated inhibition of angiogenesis. Expert Opinion on Biological Therapy. 5(3). 359–368. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact